The macroscopic evaluation revealed a dark brown-black mass 14x12x6 cm in size and 612 gr in weight, with a smooth and lobular surface and a 6 cm-long tuba uterina attached. The section showed a mostly dark brown lobulated appearance with a smooth cyst 3 cm in diameter at one corner in the inner surface.
Microscopic examination showed tumor cells with large nuclei and wide cytoplasm that formed solid sheets. The frozen section interpretation was reported as “pigmented solid ovarian tumor, probably malignant melanoma” as there was widespread brown pigment in the cytoplasm of the cells (Figure 2).
Paraffin sections showed tumor tissue that formed solid nests within the sinusoidal vessel network containing dense brown pigment with black granules in their cytoplasm. Tumor cells with large cytoplasm containing prominent nucleoli and large central nuclei could be discerned where the pigmentation was less dense (Figure 3, 4). The histochemical tests revealed a positive reaction with Masson fontana stain and negative reaction with Prussia blue stain at the pigmented areas. Immunohistochemical (IHC) evaluation showed a diffuse strongly positive reaction for HMB45 and S100 in the tumor cells and the case was reported as malignant melanoma (Figure 5).
No sign of teratoma was seen in the tumor despite obtaining many sections.
Other resection materials received for the patient showed endometrial senile cystic atrophy, an endocervical polyp in the cervix, fibrous obliteration of the appendix and chronic signet ring cholecystitis in the gallbladder. The right ovary, right tuba, omentum and intestinal mesentery looked normal. Systemic investigation revealed a nevoid lesion in the pubic region. The histopathological analysis result was intradermal nevus. The patient had a cataract in the left eye. There was no systemic pathology other than a chronic renal failure history for the past 10 years.
The case was accepted as “probable primary malignant melanoma of the ovary” as there was no previous melanoma history, no other melanoma foci were found during the physical examination and systemic evaluation and the tumor was unilateral[4].
No additional treatment was administered following the resection and the patient died with diffuse lung and bone metastases 7 months after the surgery.
Table I: Definite and probably primary ovarian melanoma cases in the literature
The differential diagnosis includes metastatic malignant melanoma and primary and secondary tumors of the ovary. It is also possible for a malignant melanoma that has regressed to have metastasized to the ovary. The metastases of the regressed tumor in various organs may be the first clinical sign in such cases.
The absence of history of malignant melanoma, pigmented skin lesions or excision, the inability to find another malignant melanoma focus despite systemic investigation and the unilateral tumor led us to diagnose this case as “probably primary malignant melanoma”.
Histology is important for ovarian malignant melanoma cases but most reports do not contain detailed histological descriptions. The most common type is the epitheliod cell type with a diffuse or nodular pattern[2]. The nodular or “nested” pattern is seen frequently in metastatic ovarian malignant melanoma[5]. Metastatic cases are usually bilateral and can rarely be unilateral.
The differential diagnosis of primary ovarian malignant melanoma contains a vast variety of pathologies. Metastatic ovarian malignant melanoma should be differentiated from malignant lymphoma, indifferentiated carcinoma, PNET and malignant sex cord stromal tumors[5].
The carcinoma diagnosis is aided by findings such as rare psammoma bodies or a relationship with endometriosis in the presence of a glandular structure. However, it must be noted that epithelial markers such as cytokeratin and EMA can be positive in malignant melanoma and negative in carcinomas that have lost their antigenicity.
The presence of large epithelioid cells in malignant surface epithelium tumors of the ovary can lead to confusion. The oxyphilic variants of endometrioid clear cell carcinomas and hepatoid carcinomas should be considered in the differential diagnosis when large epithelioid cells have a dark eosinophilic cytoplasm. Transitional cell carcinoma of the ovary can contain small glands and small spaces and can look similar to pseudopapillary-pattern malignant melanomas with cystic degeneration. IHC helps to the differential diagnosis in such cases[5].
Ovarian sarcomas can also develop on a background of dermoid cyst besides malignant melanoma. The presence of epithelioid cells and melanin pigment helps in making the malignant melanoma diagnosis. Epithelioid or spindlecell tumors that develop on a background of dermoid cyst are evaluated as carcinosarcomas. Carcinosarcomas give a positive reaction with epithelial markers and negative reaction with melanocytic markers[5].
Other tumors that are quite similar to ovarian melanomas are sex cord stromal cell tumors and steroid cell tumors. Both tumor cells have large eosinophilic cytoplasms. Steroid cell tumors are not mitotically active like malignant melanomas. They contain teratomatous elements. The presence of spindle cells and melanin pigment supports the diagnosis of malignant melanoma. Steroid cell tumors may contain lipofucsin pigment. Malignant melanoma cases can be confused with granulosa cell tumors when they consist of cells with a narrow cytoplasm. The luteinized areas of granulosa cell tumors may contain prominent nucleoli but these are usually characterized by pale vesicular nuclei. Granulosa cell tumors may also rarely be seen with a dermoid cyst. Sex cord stromal tumors are positive for inhibin and calretinin on IHC[2]. Steroid cell tumors and sex cord stromal cell tumors are S-100 and melan-A negative. HMB45 is the most specific melanocytic tumor marker but one must not forget that it can also be positive in steroid cell tumors of the ovary[5]. Dense melanin content helped in the differential diagnosis from stromal tumors in our case.
Other tumors to consider in the differential diagnosis are lymphoma, leukemia, dysgerminoma, neuroectodermal (NET) and primitive neuroectodermal tumors (PNET).
NET and PNET can be seen together with dermoid cyst and dysgerminomas can develop from a teratoma. Lymphoid and myeloid markers, PLAP, OCT-4, neuroendocrine markers, CD99 and FLI-1 are important for the differential diagnosis of these tumors in addition to melanocytic markers[5].
The dense melanin pigment of the tumor indicated malignant melanoma even at the intraoperative evaluation in our case. The typical morphology and immunohistochemical investigation provided the definite diagnosis.
1) Oliver R, Dasgupta C, Coker A, Al-Okati D, Weekes AR:
Ovarian malignant melanoma: unusual presentation of a solitary
metastasis. Gynecol Oncol 2005, 99:412-414 [ Özet ]
2) Gupta D, Deavers MT, Silva EG, Malpica A: Malignant
melanoma involving the ovary: a clinicopathologic and
immunohistochemical study of 23 cases. Am J Surg Pathol 2004,
28:771-780 [ Özet ]
3) Boscaino A, D'Antonio A, Orabona P, Tornillo L, Staibano S, De
Rosa G: Primary malignant melanoma of the ovary. Pathologica
1995, 87:685-688 [ Özet ]
4) Davis GL: Malignant melanoma arising in mature ovarian cystic
teratoma (dermoid cyst). Report of two cases and literature
analysis. Int J Gynecol Pathol 1996, 15:356-362 [ Özet ]
5) McCluggage WG, Bissonnette JP, Young RH: Primary malignant
melanoma of the ovary: a report of 9 definite or probable cases
with emphasis on their morphologic diversity and mimicry of
other primary and secondary ovarian neoplasms. Int J Gynecol
Pathol 2006, 25:321-329 [ Özet ]